Testosterone Cyp/Estradiol Cyp 50 mg/2.5 mg/mL Injection, 3mL vial, Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.
First Pharma Associates LLC
Lack of Assurance of Sterility.
Prescription and over-the-counter medications
First Pharma Associates LLC
Lack of Assurance of Sterility.
Teva Pharmaceuticals USA
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Golden State Medical Supply
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Golden State Medical Supply
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
First Pharma Associates LLC
Lack of Assurance of Sterility.
First Pharma Associates LLC
Lack of Assurance of Sterility.
First Pharma Associates LLC
Lack of Assurance of Sterility.
First Pharma Associates LLC
Lack of Assurance of Sterility.
First Pharma Associates LLC
Lack of Assurance of Sterility.
Golden State Medical Supply
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
First Pharma Associates LLC
Lack of Assurance of Sterility.
Golden State Medical Supply
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
First Pharma Associates LLC
Lack of Assurance of Sterility.
First Pharma Associates LLC
Lack of Assurance of Sterility.
First Pharma Associates LLC
Lack of Assurance of Sterility.
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.
Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.